Aldafermin Completed Phase 2 Trials for Primary Sclerosing Cholangitis (PSC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02704364Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis